Contrast-enhanced MRI after neoadjuvant chemotherapy of breast cancer: lesion-to-background parenchymal signal enhancement ratio for discriminating pathological complete response from minimal residual tumour.
Soo-Yeon KimNariya ChoSung Ui ShinHan-Byoel LeeWonshik HanIn Ae ParkBo Ra KwonSoo Yeon KimSu Hyun LeeJung Min ChangWoo Kyung MoonPublished in: European radiology (2018)
• Compared with conventional criterion, SER ≤ 1.6 criterion increased AUC and specificity. • Simple measurement of signal intensity could differentiate pCR from minimal residual cancer. • SER ≤1.6 and/or size≤0.2cm criterion showed the highest specificity of 90.4 %. • The combined criterion could be used for a study to avoid surgery.
Keyphrases
- contrast enhanced
- neoadjuvant chemotherapy
- magnetic resonance imaging
- diffusion weighted
- computed tomography
- magnetic resonance
- diffusion weighted imaging
- locally advanced
- minimally invasive
- sentinel lymph node
- papillary thyroid
- coronary artery bypass
- high intensity
- early stage
- coronary artery disease
- rectal cancer
- young adults
- radiation therapy
- surgical site infection
- breast cancer risk